Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

81.22 -0.34 (-0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
70 71 Next >
AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide. 
Via Benzinga
Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today
 
Via Benzinga
AstraZeneca Earnings Conference Call Is Coming Up, Here's What You Need To Know
 
Via Benzinga
IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer in the AEGEAN Phase III trial
From AstraZeneca
Via Business Wire
Argus Research Maintains Buy Rating for AstraZeneca: Here's What You Need To Know
 
Via Benzinga
AstraZeneca PLC (NASDAQ: AZN) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
$1000 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
3 Healthcare Dividend Payers With Big Price Growth
Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers. 
Via MarketBeat
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a... 
Via Benzinga
AstraZeneca reinforces commitment to advancing science for patients with chronic kidney disease and hyperkalemia at NKF Spring Clinical Meeting 2023
From AstraZeneca
Via Business Wire
Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay
 
Via Benzinga
2 Top Biotech Stocks to Buy Right Now
These two companies pay market-beating dividends to shareholders. 
Via The Motley Fool
AstraZeneca PLC (NASDAQ: AZN) Climbs to New 52-Week High
Via Investor Brand Network
Check Out What Whales Are Doing With AZN
 
Via Benzinga
7 Very Undervalued Penny Stocks to Buy in April 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option. 
Via InvestorPlace
Astrazeneca Plc (NASDAQ: AZN) Highlighted for Surprising Price Action
Via Investor Brand Network
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer
A combination of four drugs improved outcomes in ovarian cancer treatment. 
Via Investor's Business Daily
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
 
Via Benzinga
A Look Into AstraZeneca Inc's Price Over Earnings
 
Via Benzinga
A Look Into AstraZeneca's Debt
 
Via Benzinga
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many... 
Via Benzinga
AstraZeneca Unusual Options Activity
 
Via Benzinga
7 Growth Stocks That Pay Generous Dividends
With these seven dividend-paying growth stocks, steady payouts plus underlying growth could produce strong long-term total returns. 
Via InvestorPlace
Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively
 
Via Benzinga
AstraZeneca Axes Pneumonia Drug Pact With Aridis
AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS). 
Via Benzinga
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Sanofi and Regeneron bolted higher on news about their jointly developed COPD medication Dupixent. Analysts say sales may hit $20 billion within a decade. 
Via MarketBeat
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
 
Via Benzinga
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
From AstraZeneca
Via Business Wire
7 Blue-Chip Stocks to Buy for Capital Preservation
These are the low-beta blue-chip stocks to buy as they represent companies with a strong balance sheet and healthy cash flow potential. 
Via InvestorPlace
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
70 71 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.